AMRI Signs on to Assist in Opium-Based Drug Development

Thursday, September 3, 2015

Source: FierceCRO

Contract drugmaker AMRI ($AMRI) signed a deal with Italy's Saneca Pharmaceuticals to collaborate on opium-derived treatments, pairing up with eyes on the U.S. market for controlled substances.

View All News »